+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

DNA & Gene Chip Market by Product, Array Type, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5888580
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The DNA & Gene Chip Market grew from USD 8.77 billion in 2023 to USD 9.71 billion in 2024. It is expected to continue growing at a CAGR of 11.34%, reaching USD 18.61 billion by 2030.

The DNA & Gene Chip market is a rapidly evolving sector within biotechnology, focusing on the utilization of microarray technology for genetic analysis. The scope encompasses a range of applications including gene expression profiling, single nucleotide polymorphism (SNP) detection, and genetic mapping. The necessity for DNA & Gene Chips is driven by their efficiency in providing comprehensive genomic data, which is crucial for advancements in personalized medicine, diagnostics, and therapeutic interventions. They are particularly pivotal in applications such as cancer research, drug discovery, clinical diagnosis, and agricultural biotechnology, offering end-users like medical researchers, healthcare providers, and agricultural scientists powerful tools for genomic analysis.

Market growth is influenced by factors such as the increasing adoption of precision medicine, the need for rapid and accurate diagnostic techniques, and technological advancements in microarray platforms. Recent developments highlight opportunities in integrating AI and machine learning with gene chip data to enhance data interpretation and predictive analytics. To capitalize on these opportunities, companies need investment in R&D and collaborations with tech firms to innovate data processing and analytical capabilities. However, limitations include the high costs of technology, ethical concerns regarding genetic data privacy, and the technical challenges of data accuracy and management. Market growth is also hindered by competition from next-generation sequencing (NGS) technologies which offer broader genomic insights at competitive costs.

Innovation can focus on enhancing chip sensitivity and reducing assay times, as well as developing cost-efficient solutions that lower the entry barriers for smaller laboratories. Partnerships with software developers for robust bioinformatics tools could address data management challenges and enhance user-friendliness. Despite these hurdles, the market promises significant potential for growth, especially as personalized medicine continues to gain traction. Maintaining a dynamic understanding of regulatory landscapes, and fostering transparent communication regarding ethical practices, can help businesses navigate these challenges and leverage opportunities in the DNA & Gene Chip market.

Understanding Market Dynamics in the DNA & Gene Chip Market

The DNA & Gene Chip Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing need of DNA & gene chip for genetic analysis and diagnostics
    • Surging adoption of personalized medicines for cancer treatments
    • Increase in the demand for early cancer detection and cancer diagnosis
  • Market Restraints
    • Lack of skilled and experienced subject experts
  • Market Opportunities
    • Emerging miniaturization of DNA & gene chip
    • Strategic government fundings and initiatives for DNA & gene chip
  • Market Challenges
    • Concern associated with gene expression regulation and availability of alternative technologies

Exploring Porter’s Five Forces for the DNA & Gene Chip Market

Porter’s Five Forces framework further strengthens the insights of the DNA & Gene Chip Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the DNA & Gene Chip Market

External macro-environmental factors deeply influence the performance of the DNA & Gene Chip Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the DNA & Gene Chip Market

The DNA & Gene Chip Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the DNA & Gene Chip Market

The DNA & Gene Chip Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the DNA & Gene Chip Market

The DNA & Gene Chip Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the DNA & Gene Chip Market, highlighting leading vendors and their innovative profiles. These include 23andMe, Inc., Agilent Technologies, Inc., Arrayit Corporation, Biomérieux SA, Bioneer Corporation, CapitalBio Technology Co., Ltd., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Greiner Bio-One International GmbH, Illumina, Inc., Integrated Dna Technologies, LifeGen Technologies, LLC, Macrogen Inc., Merck KGaA, Microarrays Inc., Ocimum Biosolutions Ltd., Perkin Elmer, Inc., Promega Corporation, Savyon Diagnostics, Scienion AG by a Bico Company, Shanghai Biochip Co Ltd., Sophia Genetics SA, Surmodics Inc., Sysmex Corporation, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, and Veritas Genetics, Inc..

Market Segmentation & Coverage

This research report categorizes the DNA & Gene Chip Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Consumables
    • Instruments
  • Array Type
    • cDNA-Based Microarray
    • Oligonucleotide-Based Microarray
  • Application
    • Diagnostics
    • Drug Discovery & Development
    • Genomics
    • Personalized Medicine
  • End-User
    • Academic & Research Institutes
    • Hospitals & Clinical Laboratories
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing need of DNA & gene chip for genetic analysis and diagnostics
5.1.1.2. Surging adoption of personalized medicines for cancer treatments
5.1.1.3. Increase in the demand for early cancer detection and cancer diagnosis
5.1.2. Restraints
5.1.2.1. Lack of skilled and experienced subject experts
5.1.3. Opportunities
5.1.3.1. Emerging miniaturization of DNA & gene chip
5.1.3.2. Strategic government fundings and initiatives for DNA & gene chip
5.1.4. Challenges
5.1.4.1. Concern associated with gene expression regulation and availability of alternative technologies
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. DNA & Gene Chip Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Instruments
7. DNA & Gene Chip Market, by Array Type
7.1. Introduction
7.2. cDNA-Based Microarray
7.3. Oligonucleotide-Based Microarray
8. DNA & Gene Chip Market, by Application
8.1. Introduction
8.2. Diagnostics
8.3. Drug Discovery & Development
8.4. Genomics
8.5. Personalized Medicine
9. DNA & Gene Chip Market, by End-User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Hospitals & Clinical Laboratories
9.4. Pharmaceutical & Biotechnology Companies
10. Americas DNA & Gene Chip Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific DNA & Gene Chip Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa DNA & Gene Chip Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. DNA & GENE CHIP MARKET RESEARCH PROCESS
FIGURE 2. DNA & GENE CHIP MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DNA & GENE CHIP MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DNA & GENE CHIP MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. DNA & GENE CHIP MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. DNA & GENE CHIP MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DNA & GENE CHIP MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DNA & GENE CHIP MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DNA & GENE CHIP MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DNA & GENE CHIP MARKET DYNAMICS
TABLE 7. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DNA & GENE CHIP MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CDNA-BASED MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DNA & GENE CHIP MARKET SIZE, BY OLIGONUCLEOTIDE-BASED MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DNA & GENE CHIP MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DNA & GENE CHIP MARKET SIZE, BY HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. CANADA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. CANADA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 37. CANADA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. CANADA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. MEXICO DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. MEXICO DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 41. MEXICO DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. MEXICO DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. CHINA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. CHINA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 59. CHINA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. CHINA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. INDIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. INDIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 63. INDIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. INDIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. JAPAN DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. JAPAN DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 71. JAPAN DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. JAPAN DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. THAILAND DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. THAILAND DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 95. THAILAND DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. THAILAND DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. DENMARK DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. DENMARK DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 108. DENMARK DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. DENMARK DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. EGYPT DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. EGYPT DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 112. EGYPT DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. EGYPT DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. FINLAND DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. FINLAND DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 116. FINLAND DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. FINLAND DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. FRANCE DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. FRANCE DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 120. FRANCE DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. FRANCE DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. GERMANY DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. GERMANY DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 124. GERMANY DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. GERMANY DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. ITALY DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. ITALY DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 132. ITALY DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ITALY DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. NORWAY DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. NORWAY DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 144. NORWAY DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. NORWAY DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. POLAND DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. POLAND DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 148. POLAND DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. POLAND DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. QATAR DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. QATAR DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 152. QATAR DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. QATAR DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. SPAIN DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. SPAIN DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 168. SPAIN DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SPAIN DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. TURKEY DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. TURKEY DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 180. TURKEY DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. TURKEY DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. DNA & GENE CHIP MARKET SHARE, BY KEY PLAYER, 2023
TABLE 191. DNA & GENE CHIP MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the DNA & Gene Chip Market, which are profiled in this report, include:
  • 23andMe, Inc.
  • Agilent Technologies, Inc.
  • Arrayit Corporation
  • Biomérieux SA
  • Bioneer Corporation
  • CapitalBio Technology Co., Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Greiner Bio-One International GmbH
  • Illumina, Inc.
  • Integrated Dna Technologies
  • LifeGen Technologies, LLC
  • Macrogen Inc.
  • Merck KGaA
  • Microarrays Inc.
  • Ocimum Biosolutions Ltd.
  • Perkin Elmer, Inc.
  • Promega Corporation
  • Savyon Diagnostics
  • Scienion AG by a Bico Company
  • Shanghai Biochip Co Ltd.
  • Sophia Genetics SA
  • Surmodics Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
  • Veritas Genetics, Inc.

Methodology

Loading
LOADING...

Table Information